Clinical trial
Belviq Tablet® Post Marketing Surveillance Protocol
NCT03741010 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Belviq Tablet® Post Marketing Surveillance Protocol
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 2, 2015
- Completion date
- February 1, 2021
- Enrollment
- 3,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.